KPNA2 and SART3

  • Number of citations of the paper that reports this interaction (PMID 21988832)
  • 14
  • Data Source:
  • BioGRID (two hybrid)

KPNA2

SART3

Gene Name karyopherin alpha 2 (RAG cohort 1, importin alpha 1) squamous cell carcinoma antigen recognized by T cells 3
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 104 interactors: ACTN1 ACTN4 ANKIB1 AP2B1 APOBEC1 APP ARL4A ARL5A BRCA1 BTBD2 CASP2 CCDC107 CDA CDK5RAP3 CHD3 CHEK2 CORO1B CREB3L3 CREBBP CSE1L CSNK1A1 CUL4B DCTN2 DDIT3 EP300 EPB41 FEZ2 FN1 FTH1 GART GMCL1 GRB2 H1F0 HAP1 HMG20A HNRNPC HOMER2 HOMEZ HSPA4 IFT20 IMMT INO80E ITK JUN KLC4 KPNB1 KRT18 KRT40 KRT8 LAMB2 LEF1 LZTS2 MAGED1 MAGEH1 MDFI MLH1 MORC3 MVP MYC NECAB2 NFKBIB NMNAT1 NR3C1 NUP153 NUP50 NUP62 NUTM1 PAX5 PLAG1 PNMA5 PRKD3 PTMA RAG1 RAN RANBP2 RBM48 RBPMS RECQL RELA RELB RGL2 RILP RNMT SART3 SERTAD3 SGK1 SLC2A2 SPRY1 SRPK1 TADA2A TAF3 TAF8 TANK TBPL2 TP53 TRAF1 TRIM54 TSC22D4 TXNIP UBR5 USHBP1 ZBTB7B ZC3H12A ZNF131 12 interactors: AR C6 COIL HIST2H2AC HIST2H2BE KPNA2 LSM7 MEGF10 PRPF3 RNPS1 USP15 USP4
Entrez ID 3838 9733
HPRD ID 02818 11532
Ensembl ID ENSG00000182481 ENSG00000075856
Uniprot IDs P52292 Q7Z726 B7ZKM0 Q15020
PDB IDs 1EFX 1QGK 1QGR 3FEX 3FEY 4E4V 2DO4
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
a24  alleles  antigen  antigens  attempted  bc  cd8  ctls  efficiently  enhancer  epitope  ezh2735  hla  homolog  igg  immunotherapy  leukocyte  mononuclear  mrp3  mrp31293  multidrug  panel  peptides  polycomb  reactive  rejection  thereafter  zeste 
Tagcloud (Difference) ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
a24  alleles  antigen  antigens  attempted  bc  cd8  ctls  efficiently  enhancer  epitope  ezh2735  hla  homolog  igg  immunotherapy  leukocyte  mononuclear  mrp3  mrp31293  multidrug  panel  peptides  polycomb  reactive  rejection  thereafter  zeste 
Tagcloud (Intersection) ?